SILEXION THERAPEUTICS CORP Common Stock, Par or Stated Value Per Share
SILEXION THERAPEUTICS CORP (SLXN) had Common Stock, Par or Stated Value Per Share of $0.14 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockParOrStatedValuePerShare · last filed 2026-08-14
- 2024-06-30: Common Stock, Par or Stated Value Per Share 0.01 ILS/shares.
- 2023-12-31: Common Stock, Par or Stated Value Per Share 0.01 ILS/shares.
ILS/shares
| Period end | Common Stock, Par or Stated Value Per Share |
|---|---|
| 2024-06-30 | 0.01 ILS/shares 10-Q · filed 2024-08-29 |
| 2023-12-31 | 0.01 ILS/shares 10-Q · filed 2024-08-29 |
USD/shares
| Period end | Common Stock, Par or Stated Value Per Share | Common Stock, Par or Stated Value Per Share as first filed |
|---|---|---|
| 2026-06-30 | $0.14 10-Q · filed 2026-08-14 | |
| 2026-05-05 | $0.14 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $0.14 S-1/A · filed 2026-08-10 | $0.01 10-Q · filed 2026-05-15 |
| 2025-12-31 | $0.14 10-Q · filed 2026-08-14 | $0.01 10-K · filed 2026-03-17 |
| 2025-09-30 | $0.01 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.01 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $0.14 S-1/A · filed 2026-08-10 | $0.00 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.01 10-Q · filed 2024-08-29 | |
| 2023-12-31 | $0.01 8-K · filed 2025-08-20 | $0.00 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |